Zobrazeno 1 - 8
of 8
pro vyhledávání: '"I N, Soldatova"'
Autor:
L. A. Kesaeva, A. Yu. Bulanov, Yu. P. Finashutina, V. V. Tikhonova, O. N. Solopova, E. N. Misyurina, N. N. Kasatkina, N. A. Lyzhko, V. A. Misyurin, A. A. Turba, A. A. Solodovnik, I. N. Soldatova, A. V. Misyurin
Publikováno v:
Успехи молекулярной онкологии, Vol 6, Iss 2, Pp 48-54 (2019)
Molecular genetic detection of CALR gene somatic mutations is required for myeloproliferative neoplasms diagnosis and treatment according to the novel WHO clinical recommendations. CALR mutations are found in approximately 25–35 % cases of essentia
Externí odkaz:
https://doaj.org/article/ddc2d5ea07b847d58778f992b42fb958
Autor:
A. V. Misyurin, A. Yu. Bulanov, I. N. Soldatova, V. V. Tikhonova, E. N. Misyurina, O. N. Solopova, N. A. Lyzhko, A. A. Turba, NN Kasatkina, V. A. Misyurin, A. A. Solodovnik, Yu. P. Finashutina, L. A. Kesaeva
Publikováno v:
Uspehi Molekulârnoj Onkologii, Vol 6, Iss 2, Pp 48-54 (2019)
Molecular genetic detection of CALR gene somatic mutations is required for myeloproliferative neoplasms diagnosis and treatment according to the novel WHO clinical recommendations. CALR mutations are found in approximately 25–35 % cases of essentia
Autor:
Aston Consulting, g Shabolovka str., Moscow, Russian Federation, I. N. Soldatova, A. V. Misyurin, GenoTekhnologiya, Profsoyuznaya str., Moscow, Russian Federation, N. A. Lyzhko, NN Kasatkina, L. A. Kesaeva, YuP Finashutina, V. A. Misyurin, MA Isakov, E. N. Misyurina, V. V. Tikhonova
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 3, Pp 227-233 (2018)
Background. Kinase domain mutations of BCR-ABL gene is the most common cause of tyrosine kinase inhibitor resistance. Aim. To present the data on prognostic value of BCR-ABL mutation burden in Russian patients over the last 10 years. Materials & Meth
Autor:
SS Zborovskii, I. N. Soldatova, L. A. Kesaeva, GenoTekhnologiya, Profsoyuznaya str., Moscow, Russian Federation, A. V. Ponomarev, A. V. Misyurin, NN Kasatkina, O. N. Solopova, YuP Finashutina, N. A. Lyzhko, EI Zhelnova, AYu Bulanov, AE Bespalova, A E Misyurina, M.A. Lysenko, A. A. Krutov, DS Mar’in, V. V. Tikhonova, E. N. Misyurina, V. A. Misyurin
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 11, Iss 4, Pp 354-359 (2018)
Background. The V617F mutation of JAK2 is known to manifest in Ph-negative chronic myeloproliferative diseases (cMPD), such as polycythemia vera, thrombocythemia, and myelofibrosis. These diseases not infrequently advance into more aggressive forms u
Autor:
I. N. Soldatova, E. V. Aksenova, V. A. Misyurin, Yu. P. Finashutina, T. V. Ahlynina, A. Yu. Baryshnikov, N. A. Lyzhko, A. V. Misyurin
Publikováno v:
Russian Journal of Biotherapy. 14:19-30
Autor:
A. E. Lukina, N. A. Lyzhko, I. N. Soldatova, T. V. Akhlynina, A. V. Misyurin, V. A. Misyurin, M. A. Baryshnikova, Irina N. Mikhaylova, A. A. Krutov, O. S. Burova, L. A. Kesaeva, A. Yu. Baryshnikov, L. F. Morozova
Publikováno v:
Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 8:240-244
A growing number of evidence indicates that cancer-testis antigens (CTA) can be used as specific targets for immune therapy of malignant melanoma. The aim of this study was to provide a basis for selecting the most suitable CTA by analyzing the mRNA
Autor:
I. N. Soldatova
Publikováno v:
Marine Biology. 92:115-123
Quantitative indices of feeding, food assimilation, energy metabolism and growth in Pontogammarus maeoticus (Sow.) from the Azov Sea (12‰S) were studied from the salinity levels. Juveniles and males of different age groups were sampled for experime
Autor:
I N, Soldatova
Publikováno v:
Tsitologiia. 12(3)